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Summary
Objective
The objective of this study is to determine associations between anthropometry and
echocardiographic measures of cardiac structure and function in Hispanic/Latinos.
Methods
A total of 1,824 participants from ECHO-SOL were included. We evaluated associations
between echocardiographic measures of left ventricular structure and function and an-
thropometric measures using multivariable-adjusted linear and logistic regression
models adjusting for traditional cardiovascular risk factors.
Results
The mean age was 56 ± 0.17 years, 57% were women. The mean body mass index (BMI)
was 30 ± 9.4 kg m2, waist circumference (WC) was 100 ± 18 cm, and waist-to-hip ratio
(WHR) was 0.93 ± 0.15. Adjusted analysis showed that 5-unit increment in BMI and 5-cm
increase in WC was associated with 3.4 ± 0.6 and 1.05 ± 0.05 g m2.7 (p < 0.05 for both)
higher left ventricular (LV) mass index, respectively. Similarly, 0.1-unit increment in WHR
was associated with 2.0 ± 0.16 g m2.7 higher LV mass index (p < 0.01). WHR was asso-
ciated with 0.22 ± 0.08% decrease in ejection fraction (p < 0.05). Concomitantly, 5-unit
increment in BMI and WC was associated with increased odds of abnormal LV geometry
(odds ratio 1.40 and 1.16, p = 0.03 and <0.01, respectively); 0.1-unit increment in WHR
was associated with increased odds of abnormal LV geometry (odds ratio 1.51, p< 0.01).
Conclusions
Among Hispanic/Latinos, higher anthropometric measures were associated with adverse
cardiac structure and function.
Keywords: anthropometrics, cardiac structure and function, Hispanics.
Introduction
Obesity is an independent risk factor for the development
of heart failure (HF) (1–4). The increasing prevalence of
HF, in particular, HF with preserved ejection fraction in
the setting of the obesity pandemic (5,6), is a significant
and burgeoning public health problem (7,8).
Hispanic/Latinos are a fast-growing population with a
high prevalence of obesity (9). The overall unadjusted
prevalence of obesity among Hispanic adults from
National Health and Nutrition Examination Survey data
between 2014 and 2015 was 42.7% (10). This estimate
makes Hispanic/Latinos the second leading ethnic group
with obesity in the United States.
Concomitantly, there is accumulating evidence to sup-
port a predisposition for left ventricular (LV) dysfunction
and HF among Hispanic/Latinos (11). In this regard,
Mehta et al. showed that 50.3% of individuals from vari-
ous Hispanic/Latino backgrounds have echocardio-
graphic evidence of LV diastolic dysfunction (12).
Similarly, higher prevalence of LV hypertrophy and abnor-
mal LV remodelling has been observed in different
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Hispanic/Latino groups compared with non-Hispanic
Whites, even after adjusting for hypertension (13).
Obesity increases the risk of developing diabetes (14),
hypertension (15) and dyslipidaemia, all major risk factors
for the development of coronary heart disease (16,17).
Coronary heart disease is an important cause of HF (18).
In addition, both hypertension and diabetes are indepen-
dent risk factors for the development of HF. Furthermore,
obesity may lead to undesirable left ventricular remodel-
ling (19). Left ventricular chamber dilatation is observed
due to the chronic elevation of filling pressures and vol-
ume overload in obese individuals (20). Left ventricular
hypertrophy (LVH), concentric remodelling and concentric
LVH are associated with obesity independent of age and
arterial pressure (20). In addition to structural abnormali-
ties, obesity has adverse effects on systolic and diastolic
functions (21,22).
Preclinical echocardiographic findings of LV dysfunc-
tion in populations affected by overweight and obesity
can serve as a fundamental step to develop effective HF
preventive interventions. Hispanic/Latinos have been
identified as a group at risk for HF (11) and have high rates
of obesity (23). However, there is a lack of data evaluating
the associations between anthropometric measures and
left ventricular structure and function in US
Hispanic/Latinos. Therefore, we aimed to determine the
associations between different anthropometric and body
composition variables with echocardiographic measures
of LV structure and function in a diverse cohort of US
Hispanic/Latino adults from the Hispanic Community
Health Study/Study of Latinos (HCHS/SOL). The hypoth-
esis for this analysis was that higher levels of adiposity
are significantly associated with larger LV mass and vol-
umes but smaller ejection fraction and cardiac output.
Also, that fat fee mass will be significantly associated with
larger LV mass and volumes, as well as ejection fraction
and cardiac output.
Methods
Population
The HCHS/SOL is a multicentre community-based, pro-
spective cohort study of 16,415 self-identified Hispanics
ages 18–74 recruited from four field centres in Bronx,
NY; Chicago, IL; Miami, FL; and San Diego, CA. The
HCHS/SOL was designed to examine the risk and protec-
tive factors for chronic diseases and associated morbidity
and mortality among Hispanic/Latinos in the United
States. The HCHS/SOL is composed of individuals from
the following heritage: Central American (n = 1,732),
Cuban (n = 2,348), Dominican (n = 1,473), Mexican
(n = 6,472), Puerto-Rican (n = 2,728) and South American
(n = 1,072). Details on the sampling and designs have
been published separately (24).
The echocardiographic study of Latinos (ECHO-SOL)
is an ancillary study to the HCHS/SOL designed to
characterize cardiac structure and function and their
determinants. The study population consists of 1,824
participants, approximately 450 individuals from each
field centre. Individuals older than 45 years of age who
met eligibility criterial for the HCHS/SOL and who had
completed all baseline examinations were eligible
participants for ECHO-SOL. All echocardiograms for
ECHO-SOL were completed after baseline examination
but within 36 months of initial collection of clinical and
laboratory data. Stratified random sampling was used,
drawing participants from the communities representing
the four field centres to provide a population sample
representative of the HCHS/SOL population and the
Hispanic subgroups characteristic of the field centres.
Details on the methodology for the ECHO-SOL study
have been published (25).
Echocardiographic measurements
ECHO-SOL field imaging centres were established using
existing echocardiographic equipment from the
HCHS/SOL at each of the four field centres. Phillips Ultra-
sounds IE-33 (Philips Health Care, Andover, MA, USA) or
Sonos 5500/7500 ultrasound imaging platform were used
in all field imaging centres. Under a standardized protocol
and after completion of in-person training, experienced
sonographers in each field centre completed standard
echocardiographic examinations including two-
dimensional imaging with harmonics spectral Doppler
and tissue Doppler. Digital echocardiographic images
were electronically transferred from the field centres to
the Core Lab at Wake Forest School of Medicine. All
ECHO-SOL echocardiograms were read by a cardiologist
with experience in echocardiography (Dr Rodriguez). In
order to confirm accuracy of key quantitative measures,
echocardiogram over-reads were performed. Inter and
intra-reader reproducibility was assessed and previously
published (25). Intra-class correlations for inter-reader
reproducibility ranged from 0.80 to 0.99 with left atrial
volume and LV end-diastolic volumes having the highest
intra-class correlation values (0.97–0.99).
LV chamber size and wall thickness linear dimensions
were used to calculate LV mass (LVM). LVM was indexed
(LVMI) to height2.7. Relative wall thickness (RWT) was
defined as 2 * (LV Posterior Wall Thickness ∕ LV internal
diameter at diastole). The bi-plane method of disc
(Simpson’s method) was used to obtain LV volumes,
and ejection fraction (EF) was calculated from the formula
EF = EDV – ESV ∕ EDV; where EDV and ESV are the
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volumetric measurements of LV end-diastolic and end-
systolic volumes, respectively. LV stroke volume (SV), re-
ported in mL, was assessed utilizing LV outflow tract
(LVOT) dimensions, measured in cm2 and pulse wave
spectral Doppler for LV outflow tract Velocity Time Inte-
gral. Cardiac output (CO) is the SV multiplied by heart
rate. LV diastolic function was assessed with pulse wave
mitral inflow velocities (E and A), tissue Doppler mitral
annular velocities (e’ septal and e’ lateral) and left atrial
volume (LAV) measured in biplane views index to body
surface area. LV diastolic function was categorized as
Grade I (mild) to Grade III (severe) according to published
ASE (American Society of Echocardiography) and
Redfield definitions (26). Left ventricular geometry was
categorized as normal, concentric remodelling, concen-
tric hypertrophy and eccentric hypertrophy using LVMI2.7
and RWT. The cuff off value for normal LVMI2.7 was 45
and for RWT was 0.42 (27).
Anthropometric measurements
The participants wore light clothing and slippers for all
measurements and were barefoot whenmeasuring weight
and body composition. Standing height was measured
with a fixed stadiometer with a vertical backboard and
moveable headboard. Weight and body composition was
measured with the Tanita Body Composition Analyser,
TBF-300A (Tanita Corporation of America, Inc., Arlington
Heights, IL, USA). Body mass index (BMI) was calculated
averaging two body weight measurements and two stand-
ing height measures. The World Health Organization BMI
classification was used: normal = 18.5–25 kg m2,
overweight = 25–29.99 kg m2 and obese ≥ 30 kg m2.
Waist circumference (WC) was measured at the level of
the upper border of the iliac crest. WC measurement
was done using Gulick II 150 and 250 anthropometric
tapes (Sammons Preston, Chicago, IL, USA). Hip
circumference (HC) was measured at the level of
maximum protrusion of the buttocks. Waist-to-hip ratio
(WHR) was defined as the WC divided by the HC. The
Tanita scale used bioelectrical impedance to measure
the participant’s total body fat percent, fat mass (FM)
and lean body mass to calculate the fat-free mass (FFM).
Clinical covariates
All variables were obtained using methods that have been
previously described (24). Briefly, an interviewer-
administered questionnaire was used to assess
participants’ medical history. Participants were fasting
12 h before providing venous blood samples. Laboratory
measurements from blood included total cholesterol,
high-density lipoprotein (HDL) cholesterol, triglycerides,
glucose and creatinine. Dyslipidaemia was defined as to-
tal cholesterol of 240 mg dL1 or greater, low-density li-
poprotein cholesterol 160 mg dL1 or greater or HDL
cholesterol less than 40 mg dL1, or receiving
cholesterol-lowering medication. Diabetes was defined
as a fasting plasma glucose level of 126 mg dL1 or
greater, 2 h post-load glucose 200 mg dL1 or greater,
or A1c of 6.5 or greater or taking antihyperglycaemic
medication. Normal range plasma creatinine was 0.5–
1.2 mg dL1 for men and 0.4–1.0 mg dL1 for women
(28). Three-seated blood pressure measurements were
obtained with an automatic sphygmomanometer; the
second and third reading were averaged. Hypertension
was defined as a systolic blood pressure ≥ 140 mmHg,
or diastolic blood pressure ≥ 90 mmHg or taking blood
pressure medication.
Data analysis
Continuous variables were presented as means (SD) and
categorical variables as counts (percentage). Continuous
variables were compared using simple regression
analysis across categories of BMI. Categorical variables
were compared using Rao–Scott Chi-square test across
categories of BMI. We tested associations between
various anthropometric parameter (BMI, WC, HC, WHR,
FM and FFM) and the echocardiographic parameter of
cardiac structure and function using multivariable linear
regressionmodels. Usingmultivariable logistic regression,
we also tested the association between anthropometric
measures and diastolic dysfunction and left ventricular
geometry. Diastolic dysfunction was defined as normal
or abnormal (class I-III), and left ventricular geometry was
normal or abnormal (if concentric remodelling, eccentric
remodelling or concentric hypertrophy was identified).
The covariates, for both multivariable linear and logistic
regression, included age, gender, height (except when
BMI was the predictor variable), FFM (except when FFM
was the predictor variable), hypertension and taking antihy-
pertensive medications, diabetes, dyslipidaemia, smoking
and family history of cardiacdisease. Statistical significance
wasdefined as ap value < 0.05. Survey methods were uti-
lized, and all reported values were weighted to adjust for
sampling probability and nonresponse bias to make the
inference applicable to the ECHO-SOL target population.
All analyses were performed using PROC SURVEY with
SAS version 9.3 (SAS Institute Inc, Cary, NC).
Results
The average age was 56 ± 0.17 years, and 57% of partic-
ipants were women. Mean values for blood pressure (sys-
tolic blood pressure 136 ± 38 mmHg and diastolic blood
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pressure 78 ± 34 mmHg), HDL cholesterol
(50 ± 17 mg dL1) and serum creatinine
(0.8 ± 0.13 mg dL1) were within the normal range. The
mean BMI was 30 ± 9.4 kg m2, WC = 100 ± 18 cm, fat
mass = 29 ± 16 kg, and fat-free mass = 50 ± 13 kg. The
mean LVEF was 60 ± 8.5%, LVMI = 42 ± 15 g m2.7,
ESV = 34 ± 17 mL, EDV = 84 ± 37 mL and
CO = 5 ± 2.1 L min1. Please refer to Table 1.
As shown in Table 2, among those with obesity, 67%
were women, those with overweight included 51%
women compared with 48% women in those with normal
BMI (p value < 0.0001). People with obesity had lower
rates of smoking compared with individuals with normal
BMI (13% vs. 29%, p < 0.0001). The proportion of
participants with diabetes, hypertension and
dyslipidaemia was higher in individuals with obesity
(37%, 56.2% and 44.3%) and overweight (23.1%,
46.3% and 40.9%) compared with those with a normal
BMI (17.5%, 41.6% and 31.4%).
Mean echocardiographic measures of LVMI, ESV, EDV,
SV and CO were higher among those with obesity
(45.2 g m2.7, 35 mL, 86.8 mL, 73 mL and 4.8 L)
compared with those with normal BMI (34.7 g m2.7,
32.4 mL, 79.4 mL, 65.7 mL and 4.2 L, and 79.4 mL, p
value < 0.05 for all comparisons) The lateral and septal
E/E’ was higher for those with obesity (9.3 and
12.5 m s1) compared with people with normal BMI (8.2
and 10.7 m s1; p value < 0.0001 for both comparisons).
The rate of eccentric remodelling and concentric hyper-
trophy was higher in people with obesity (16.8% and
21.2%) than those with normal BMI (2.7% and 3.8%; p
value < 0.0001). Furthermore, the rate of normal LV ge-
ometry was higher in those with normal BMI compared
with those with obesity (76.9% and 46.4%; p
value < 0.0001). Diastolic dysfunction grade 1 and grade
2 were higher among people with obesity (17.4% and
48.6%) and overweight (19.7% and 37.4%) compared
with the normal BMI group (12.2% and 30.3%;
p value = 0.0001). Similar diastolic dysfunction, the pro-
portion of individuals with normal LV geometry was lower
in people with obesity compared with those with normal
BMI (46.4% and 76.9%; p value < 0.0001).
In linear regression models adjusted for age, gender,
FFM and cardiovascular risk factors, every 5-unit incre-
ment in BMI was associated with a 3.4 g m2.7 increase
in LVMI (p < 0.05), a 101.5-mL increase in CO (p < 0.05)
and a 0.45 higher E/E’ ratio (p < 0.05). Similarly, for every
5-cm increase in WC was associated with a 1.05 g m2.7
increase in LVMI (p < 0.01), a 0.15-mL increase in ESV
(p < 0.02), a 0.40-mL increase in EDV (p < 0.05), a
43.5 mL min1 increase in CO (p < 0.01), a 0.35-ml in-
crease LAV (p < 0.01) and a 0.1 higher E/E’ ratio
(p < 0.01). Similar findings were noted for HC, FM, and
FFM, please refer to Table 3. However, each 0.1-unit in-
crement in WHR was associated with a 2.0 g m2.7 in-
crease in LVMI (p < 0.01), and a 0.22 decrease in EF
(p < 0.01), as well as a 0.66-mL decrease in ESV
(p < 0.01) and 1.71-mL decrease in EDV (p < 0.01).
To summarize, BMI, WC, HC, FM and FFR were all as-
sociated with higher LVMI, CO, LAV and E/E’ independent
of age, sex, hypertension and antihypertensive medica-
tion use, diabetes, dyslipidaemia, smoking and family his-
tory of coronary heart disease. In the other hand, WHR
was associated with higher LVMI but lower ESV, EDV
and EF.
In multivariable logistic regression models (Table 4), ev-
ery 5 kg m‑2 increase in BMI was associated with higher
odds of abnormal left ventricular geometry (odds ratio,
OR 1.40, 95% confidence interval, CI [1.3, 1.9]) and dia-
stolic dysfunction (OR 1.48, 95% CI [1.2, 1.8], p < 0.01).
Similarly, each 5-cm increase in WC was associated with
increased odds of abnormal left ventricular geometry (OR
1.17, 95% CI [1.09, 1.26]) and increased odds of diastolic
dysfunction (OR 1.1, 95% CI [1.01, 1.2]). Each 0.1-unit in-
crease in WHR was associated with higher odds of
Table 1 Baseline characteristics
Mean (SE)
Age (years) 56 ± 0.17
SBP (mmHg) 136 ± 38
DBP (mmHg) 78 ± 34
Heart rate (bpm) 66 ± 24
HDL cholesterol (mg dL1) 50 ± 17
Serum Cr (mg dL1) 0.8 ± 0.13
BMI (kg m2) 30 ± 9.4
Waist circumference (cm) 100 ± 18
Hip circumference (cm) 107 ± 21
Waist-to-hip ratio 0.93 ± 0.15
Fat mass (kg) 29 ± 16
Fat free mass (kg) 50 ± 13
Height (cm) 163 ± 17
N (%)
Women (%) 882 (57)
Diabetes (%) 523 (28)
Current smokers (%) 210 (18)
Echocardiographic parameters Mean (SE)
Left ventricular mass index (g m2.7) 42 ± 15
End systolic volume (mL) 34 ± 17
End diastolic volume (mL) 84 ± 37
Ejection fraction (%) 60 ± 8.5
Fractional shortening (%) 30 ± 12
Cardiac output (L min1) 5 ± 2.1
Lateral peak systolic velocity (cm s1) 8 ± 4.3
Data are presented as mean ± SD or N (%) using weighted row
percentages.
BMI, body mass index; DBP, diastolic blood pressure; HDL, high-
density lipoprotein; SBP, systolic blood pressure; SE, standard error.
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abnormal left ventricular geometry (OR 1.51, 95% CI
[1.12, 2.03]), but WHR was not significantly associated
with diastolic dysfunction (OR 1.18, 95% CI [0.93, 1.48]).
Every 1-kg increase in FM and FFM was associated
higher odds of abnormal left ventricular geometry (OR
1.03, 95% [CI 1.0, 1.05] and OR 1.02, 95% CI [0.98,
1.05], respectively) and higher odds of diastolic
dysfunction (OR 1.02, 95% CI [1.0, 1.04] and OR 1.06,
95% CI [1.02, 1.10]).
In summary, BMI, WC, WHR and FM were associated
with statistically significant higher odds of abnormal left
ventricular geometry. Similarly, BMI, WC, FM and FFM
were associated with higher odds of diastolic
dysfunction.
Table 2 Unadjusted associations between baseline characteristics and BMI
Clinical and
echo characteristic
BMI
<25 (N = 225) 25–29 (N = 529) >30 (N = 598) Overall p value
Mean SE Mean SE p value Mean SE p value
Age (years) 56 0.73 57 0.46 0.68 56 0.63 0.82 <0.0001
Lean body mass (kg) 46 0.6 49 0.48 0.0007 52 0.53 <0.0001 <0.0001
Fat mass (kg) 16 0.29 24 0.19 <0.0001 38 0.5 <0.0001 <0.0001
WC (cm) 85.5 0.61 95 0.33 <0.0001 109.1 0.69 <0.0001 <0.0001
SBP (mmHg) 133.3 0.43 135.4 0.99 0.24 137.9 1.07 0.01 <0.0001
DBP (mmHg) 74.8 0.76 77.7 0.68 <0.01 79.2 0.49 <0.0001 <0.0001
HDL (mg dL1) 55.5 1.27 54.8 0.59 <0.01 48.3 0.53 <0.0001 <0.0001
Creatinine (mg dL1) 0.94 0.06 0.86 0.015 0.21 0.8 0.01 0.03 <0.0001
LVMI (g m2.7) 34.7 0.57 40.1 0.53 <0.0001 45.2 0.55 <0.0001 <0.0001
LVPWd (cm) 0.81 0.01 0.89 0.01 <0.0001 0.91 0.01 <0.0001 <0.0001
IVSd (cm) 1 0.01 1 0.01 <0.0001 1.11 0.01 <0.0001 <0.0001
RWT 0.37 0.01 0.37 0.01 <0.0001 0.4 0.01 <0.0001 <0.0001
ESV, mean 32.4 0.88 32.9 0.59 0.59 35 0.48 0.01 <0.0001
EDV, mean 79.4 1.89 81.5 1.07 0.31 86.8 1.02 <0.01 <0.001
EF, mean 59.4 0.4 59.9 0.29 0.2 59.8 0.25 0.32 <0.0001
SV (LVOT) (mL) 65.7 1.1 69.1 0.97 0.02 73 0.95 <0.0001 <0.0001
CO (L) 4.2 0.079 4.5 0.071 <0.01 4.8 0.06 <0.0001 <0.0001
E/E’ lateral ratio (mean) 8.2 0.18 8.7 0.27 0.04 9.3 0.29 <0.0001 <0.0001
E/E’ septal ratio (mean) 10.7 0.25 11.1 0.19 0.29 12.5 0.2 <0.0001 <0.0001
LA volume 39.6 1.15 42.4 0.73 0.04 43.5 0.6 0.001 <0.001
Percent Percent Percent p value
Women 48 51 67 <0.0001
Current smoker 29 18 13 <0.0001
Current alcohol use 47 49 38 0.014
Diabetes 17.6 23.1 37 <0.0001
Hypertension 41.5 46.3 56.2 0.0024
Dyslipidaemia 32.2 40.9 44.3 0.05
Left ventricular geometry <0.0001
Normal (%) 76.9 56.8 46.4
CR (%) 16.6 23.3 15.6
ER (%) 2.7 7.7 16.8
CH (%) 3.8 12.2 21.2
LV diastolic function <0.0001
Normal 55.4 41.1 31.8
Grade 1 (%) 12.2 19.7 17.4
Grade 2 (%) 30.3 37.4 48.6
Grade 3 (%) 2.1 1.8 2.2
Data are presented as mean or N (%) using weighted row percentages; N’s presented are unweighted counts of total participants in the HCHS-
SOL with respective characteristic.
BMI, body mass index; CO, cardiac output; CR, concentric hypertrophy; DBP, diastolic blood pressure; EDV, end-diastolic volume; EF, ejection
fraction; ER, eccentric hypertrophy; ESV, end-systolic volume; HDL, high-density lipoprotein; IVSd, interventricular septum thickness; LA, left
atrial; LV, left ventricular; LVMI, left ventricular mass index; LVOT, left ventricular outflow tract; LVPWd, left ventricular posterior wall thickness;
RWT, relative wall thickness; SBP, systolic blood pressure; SE, standard error; SV, stroke volume; WC, waist circumference.
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Discussion
In this cross-sectional analysis of the association be-
tween anthropometrics, body composition measures
and echocardiographic measures of left ventricular struc-
ture and function in Hispanic/Latinos, we found that
higher anthropometrics and body composition measures
were associated with undesirable cardiac structure and
function. Specifically, BMI, WC, HC, FM and FFM were
associated with higher LVMI, CO and E/E’, while WHR
was significantly associated with higher LVMI and lower
ESV, EDV and lower EF. Similarly, BMI, WC and FM were
associated with abnormal left ventricular geometry (ec-
centric remodelling, eccentric hypertrophy and concen-
tric hypertrophy) and diastolic dysfunction (grades I–III).
These associations were independent of age, sex, diabe-
tes, hypertension, dyslipidaemia, smoking and personal
and family history of cardiovascular disease.
Hispanic/Latinos are a fast-growing minority in the
USA with high prevalence of obesity and other cardiovas-
cular risk factors (9) that place them at increased risk for
the development of HF (11). Our study shows that higher
anthropometric measures are associated with higher
LVMI and CO but lower EF except for BMI for which EF
is higher. Also, higher anthropometrics are associated
with abnormal left ventricular geometry (concentric re-
modelling, concentric hypertrophy and eccentric hyper-
trophy) after adjusting for traditional cardiovascular risk
factors including hypertension, dyslipidaemia, smoking
and personal and family history of cardiovascular dis-
ease. Abnormal LV geometry is commonly observed in
patients with normal LV systolic function. Unfortunately,
abnormal LV geometry with or without LVH is associated
with adverse outcomes. Older and obese patients are
more commonly found to have abnormal LV geometry
patterns (29).
Obesity can influence the development of left ventric-
ular hypertrophy, and therefore, abnormalities in left
ventricular geometry through increase haemodynamic
load (3) and inflammation THAT promote adverse cardiac
remodeling (30). Hypertension is strongly correlated with
obesity (15), and hypertension is known to be associated
with eccentric left ventricular hypertrophy. Although it is
difficult to separate the effect of hypertension from that
of obesity, we included hypertension in our linear and
logistic regression models to account for this known
Table 3 Multivariable linear regression models of the associations between anthropometric measures and echocardiographic parameters
LVMI ESV EDV EF CO LAV E/E’
Predictor B (SE) R2 B (SE) R2 B (SE) R2 B (SE) R2 B (SE) R2 B (SE) R2 B (SE) R2
BMI 3.4 (0.60)* 0.21 0.5 (0.45) 0.3 1.75 (1) 0.34 0.1 (0.20) 0.06 101.5 (49.5)* 0.19 0.3 (0.6) 0.12 0.45 (0.12)* 0.21
WC 1.05 (0.05)* 0.22 0.15 (0.05)* 0.3 0.40 (0.1)* 0.34 0.05 (0.04) 0.07 43.5 (12.5)* 0.19 0.35 (0.1)* 0.12 0.10 (0.01)* 0.21
HC 0.55 (0.04)* 0.2 0.30 (0.05)* 0.3 0.85 (0.1)* 0.35 0.01 (0.03) 0.07 38 (11.5)* 0.19 0.25 (0.05)* 0.12 0.10 (0.01)* 0.21
WHR 2.00 (0.16)* 0.2 0.66 (0.13)* 0.3 1.71 (0.29)* 0.35 0.22 (0.08)* 0.07 29.3 (18.5)* 0.19 0.32 (0.23) 0.12 0.05 (0.05) 0.20
FM 0.19 (0.01)* 0.21 0.08 (0.01)* 0.3 0.26 (0.03)* 0.35 0.001 (0.01) 0.07 12.5 (3.7)* 0.19 0.1 (0.02)* 0.12 0.02 (0.00)* 0.21
FFM 0.41 (0.06)* 0.15 0.52 (0.07)* 0.3 1.2 (0.16)* 0.34 0.01 (0.03) 0.06 68.0 (8.3)* 0.19 0.57 (0.08)* 0.12 0.04 (0.01)* 0.19
Model adjusted for age, gender, height (except for BMI models where height has been omitted), FFM (except for FFM models), HTN, DM,
dyslipidaemia, smoking and family history of coronary heart disease.
*p value <0.05.
BMI, body mass index; CO, cardiac output; DM, diabetes mellitus; EDV, end-diastolic volume; EF, ejection fraction; ESV, end-systolic volume;
FFM, fat-free mass; FM, fat mass; HC, hip circumference; HTN, hypertension; LAV, left atrial volume; LVMI, left ventricular mass index; SE, stan-
dard error; WC, waist circumference; WHR, waist-to-hip ratio.
Table 4 Multivariable logistic regression models of the associations
between anthropometric measures and echocardiographic
parameters
LV geometry Diastolic dysfunction
Odds
ratio 95% CI p value
Odds
ratio 95% CI p value
BMI 1.40 [1.30, 1.90] 0.03 1.48 [1.20, 1.80] <0.01
WC 1.17 [1.09, 1.26] <0.01 1.10 [1.01, 1.20] 0.04
HC 1.05 [0.94, 1.17] 0.41 1.07 [0.98, 1.17] 0.13
WHR 1.51 [1.12, 2.03] <0.01 1.18 [0.93, 1.48] 0.22
FM 1.03 [1.00, 1.05] 0.02 1.02 [1.0, 1.04] 0.05
FFM 1.02 [0.98, 1.05] 0.42 1.06 [1.02, 1.10] 0.03
Model 1: Age, gender, height (except for BMI models where height
has been omitted), FFM (except FFM which is adjusted for FM),
HTN, DM, dyslipidaemia, smoking and family history of coronary
heart disease.
Left ventricular geometry is categorized as normal versus abnormal.
The abnormal category includes left ventricular eccentric remodel-
ling, eccentric hypertrophy and concentric hypertrophy.
BMI, body mass index; CI, confidence interval; FFM, fat-free mass;
FM, fat mass; HC, hip circumference; WC, waist circumference;
WHR, waist-to-hip ratio.
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association. Similarly, obesity and diabetes are strongly
associated (31), and both are pro-inflammatory condi-
tions that could lead to adverse cardiac remodelling (high
LVMI) (30). Diabetes was therefore included in our models
as a confounder for the association between obesity and
cardiac structure. Our final results demonstrate an
independent association between obesity and higher
LVMI and abnormal left ventricular geometry after
adjusting for major confounders such as hypertension
and diabetes.
Higher BMI, WC, HC, FM and FFM were associated
with higher E/E’ and left ventricular diastolic dysfunction
independent of age, sex and common cardiovascular
risk factors. Left ventricular diastolic dysfunction is a
finding related to abnormal cardiac filling pressure during
the relaxation phase of the cardiac cycle and is associ-
ated with an increased risk of future HF risk (32). Simi-
larly, E/E’ is a widely used indicator of left ventricular
filling pressures and predictor of HF risk (33,34). While
previous studies have documented the association be-
tween obesity and abnormal cardiac structure and func-
tion (21,35–38), there is lack of data describing these
associations in US Hispanic/Latinos. Among the existing
studies, the sample might not be representative or the
US Hispanic/Latino population (39). Our study provides
data to fill in this gap and serves as the groundwork to
inform prospective and intervention studies aimed to
determine the use of echocardiography as a risk stratifi-
cation tool for HF in US Hispanic/Latinos affected by
overweight and obesity.
Our study limitations include recruitment of specific
Hispanic/Latino background groups by study site be-
cause of differential geographic distribution among
Hispanic/Latino groups residing in the United States.
The ECHO-SOL echocardiograms were not contempora-
neous with data from the HCHS/SOL. However, the time
intervals between ECHO-SOL assessment and
HCHS/SOL measurements were reduced to the best pos-
sible, and the most updated HCHS/SOL data on key co-
variates (hypertension, diabetes mellitus and self-
reported HF) were used. The cross-sectional nature of
the analysis limits causal inference and is prone to poten-
tial reverse causality. Furthermore, our study lacks clinical
outcomes.
The strengths of this study include the use of a large
and diverse US Hispanic/Latino population sample with
standardized comprehensive anthropometric and echo-
cardiographic measures of cardiac structure and func-
tion. We provide information on the association between
various measures of adiposity rather than limiting to com-
monly used BMI and WHR. The inclusion of WC, HC, FM
and FFM allows for assessment of different body fat dis-
tribution patterns important to the population studied.
Conclusion
Understanding anthropometrics and body composition
measures and their relationship to echocardiographic
markers of left ventricular dysfunction aid in identifying
populations at risk for HF. The findings from this cross-
sectional analysis contribute the first comprehensive an-
thropometric and body composition analysis reporting the
associationswith echocardiographicmeasures of LV struc-
ture and function in a large cohort of US Hispanic/Latinos.
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